Kangmei Pharma | 600518 - Loan Capital



Kangmei Pharma reported CNY84.24M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Alaunos Therapeutics USD 0 0 Dec/2024
Avita Medical AUD 42.24M 1.25M Dec/2024
Cspc Pharmaceutical CNY 56.14M 10.18M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Genomma Lab Internacional MXN 5.03B 1.04B Jun/2025
Hypermarcas BRL 7.44B 131.55M Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
IQVIA Holdings USD 14.18B 1.07B Jun/2025
Jiangsu Hengrui CNY 45.47M 17.24M Jun/2025
Kangmei Pharma CNY 84.24M 3.67M Jun/2025
Moderna USD 32M 3M Jun/2025
Organon & Co USD 8.9B 36M Jun/2025
Revvity USD 3.21B 45.94M Jun/2025
Sh Fosun Pharma CNY 14.6B 412.93M Jun/2025
Tectonic Therapeutic USD 186K 201K Jun/2025
Viatris USD 12.79B 1.39B Jun/2025
Wuxi Apptec CNY 1.5B 107.88M Jun/2025
Xeris Pharmaceuticals USD 218.63M 1.62M Jun/2025
Zz Pientze Pharmaceu 196.31M 8.23M Jun/2025